XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SCHEDULE OF BUSINESS SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Segment Reporting Information [Line Items]          
Total assets $ 6,906   $ 6,906   $ 725
Total revenue 28 $ 12 35 $ 25  
Net loss (2,163) (11,293) (3,667) (18,932)  
Net loss (570) (557) (937) (1,494)  
Impairments of intangible assets (2,633) (2,633)  
2022 Debenture Release and PIK Note Amendment (3,521) (3,521)  
Interest expense (542) (492) (843) (717)  
Health Cares [Member]          
Segment Reporting Information [Line Items]          
Total assets 4,341   4,341  
Total revenue 20      
Net loss (67)      
Labs And Life [Member]          
Segment Reporting Information [Line Items]          
Total assets 2,435   2,435   408
Total revenue 8 12      
Net loss (503) (557)      
Corporate Segment and Other Operating Segment [Member]          
Segment Reporting Information [Line Items]          
Total assets 130   130   $ 317
Total revenue [1] [1] [2] [2]  
Net loss $ (1,051) [1] $ (4,090) [1] (1,887) [2] (10,567) [2]  
Other Operating Segment [Member] | Health Care [Member]          
Segment Reporting Information [Line Items]          
Total revenue     20  
Net loss     (67)  
Other Operating Segment [Member] | Labs And Life [Member]          
Segment Reporting Information [Line Items]          
Total revenue     15 25  
Net loss     $ (870) $ (1,494)  
[1] For the three months ended June 30, 2024, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $144 and depreciation and amortization expense of $52. For the three months ended June 30, 2023, Corporate and other includes stock-based compensation, including consulting agreement expense, of $1,268 and depreciation and amortization expense of $247.
[2] For the six months ended June 30, 2024, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $288 and depreciation and amortization expense of $104. For the six months ended June 30, 2023, Corporate and other includes stock-based compensation, including consulting agreement expense, of $3,894 and depreciation and amortization expense of $1,176.